longbridge

Bolt Biotherapeutics

BOLT
----

All Shareholders

Shareholder Type

  • Public and others65.48%
  • Institutions18.69%
  • VC/PE firms7.15%
  • Hedge funds5.12%
  • Individuals & Insiders3.55%

Major Shareholders

Major Shareholders Latest
Shareholder
Sofinnova Investments, Inc.
7.15%137.72K0.02%+0
Renaissance Technologies LLC
5.12%98.63K1.10%+21.40K
Vivo Capital, LLC
3.76%72.41K<0.01%+0
Citadel Advisors LLC
2.95%56.90K2.43%+46.79K
T3 Trading Group, LLC
1.97%38.00K0.00%+0
Stanford Management Company
1.87%35.98K<0.01%+0
Pfizer Venture Investments LLC
1.63%31.31K<0.01%+0
Lynx1 Capital Management LP
1.60%30.80K<0.01%+0
Nano-Cap New Millennium Advisors, Llc
1.43%27.50K<0.01%+0
William QuinnCEO, CFO, President, Secretary & Director
1.32%25.38K1.20%+23.07K
Geode Capital Management, LLC
0.99%19.12K0.51%-9.67K
Grant YonehiroCOO & Chief Business Officer
0.90%17.27K0.87%+16.82K
Sarah NemecSenior VP of Finance & Principal Accounting Officer
0.89%17.08K0.84%+16.13K
Shay Capital LLC
0.80%15.44K0.03%+533.00
Vanguard Capital Management, LLC
0.53%10.16K<0.01%+0
BlackRock, Inc.
0.50%9.71K<0.01%+0
Kam Chung Leung
0.45%8.68K<0.01%+0
Pivotal BioVenture Partners LLC
0.26%5.00K3.48%-66.83K
Morgan Stanley
0.16%3.15K<0.01%-44.00
NewEdge Advisors, LLC
0.13%2.53K--+2.53K
© 2026 Longbridge｜Terms of ServicePrivacy Policy